70
Participants
Start Date
March 25, 2020
Primary Completion Date
August 17, 2020
Study Completion Date
August 17, 2020
Hydroxychloroquine
200mg tablet; 800 mg orally once, followed in 6 to 8 hours by 600 mg, then 600mg once a day for 4 consecutive days
Placebo oral tablet
4 placebo tablets once, followed in 6 to 8 hours by 3 tablets, then 3 tablets once-a-day for 4 consecutive days
University of Minnesota, Minneapolis
University of Alberta, Edmonton
University of British Columbia, Vancouver
University of Manitoba, Winnipeg
Eastern Health, St. John's
McMaster University, Hamilton
Lawson Health Research Institute, London
Research Institute of the McGill University Health Centre, Montreal
Collaborators (1)
University of Manitoba
OTHER
University of Alberta
OTHER
University of British Columbia
OTHER
McMaster University
OTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER
Eastern Health
OTHER
University of Minnesota
OTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER